Viking Therapeutics faces higher bar for oral weight-loss drug after ...

Mar 11, 2024 · Viking Therapeutics Inc.'s stock fell 5.6% Friday, in a pullback from recent highs, after strong data from Novo Nordisk on an oral version of its weight-loss drug raised the …

CouponFollow Extension

6%
OFF

Viking Therapeutics Faces Higher Bar For Oral Weight-loss Drug After ...

6 days from now

Mar 11, 2024 · Viking Therapeutics Inc.'s stock fell 5.6% Friday, in a pullback from recent highs, after strong data from Novo Nordisk on an oral version of its weight-loss drug raised the …

morningstar.com

3%
OFF

Viking Therapeutics' Early Clinical Data Continue To Build Case For …

6 days from now

Nov 4, 2024 · This past spring, Viking reported preliminary Phase 1 data for oral VK2735 showing an average placebo-adjusted weight loss of 3.3% after 28 days. In those results, the highest of …

medcitynews.com

3%
OFF

Viking Therapeutics Reports New Data From VK2735 Obesity …

6 days from now

Nov 4, 2024 · Persistent weight loss effects were observed at follow-up visits through Day 57, ranging up to 8.3% from baseline, four weeks after the last dose of VK2735 was administered. …

vikingtherapeutics.com

8%
OFF

Viking Oral Obesity Med Posts 6.8% Weight Loss For Highest Dose

6 days from now

Nov 4, 2024 · While the lowest doses failed to beat placebo, the 20-mg dose was tied to a 2.2% placebo-adjusted mean weight reduction, with a 3.7% weight loss linked to the 40-mg dose, a …

fiercebiotech.com

2%
OFF

Viking Therapeutics' Weight-loss Pill Shows 'great Outcome' In Trial

6 days from now

Nov 4, 2024 · Oral GLP-1 drug in study led to average weight loss of 8.2% in a month at a 100 mg dose Viking Therapeutics Inc. cheered analysts Monday after the biotech posted data on its …

morningstar.com

2%
OFF

Viking Slips As Manufacturing Concerns Cloud Promising Oral …

6 days from now

Nov 4, 2024 · Smaller rival Structure's experimental oral obesity drug was shown to help reduce weight by 6.2% on average in a mid-stage study. Its shares were down 2.5% at $40.09.

reuters.com

104%
OFF

Viking Therapeutics Soars 104% After Its GLP-1 Weight-loss Drug …

6 days from now

Feb 28, 2024 · Viking Therapeutics stock soared as much as 104% on Tuesday after a successful drug trial. Viking's GLP-1 weight loss drug led to a significant reduction in body weight among …

yahoo.com

3%
OFF

Oral Obesity Drug From Viking Therapeutics Hits Key Early Target

6 days from now

Mar 26, 2024 · In preview notes, analysts had said that investors would want to see between 3% and 4% placebo-adjusted weight loss. Shares of San Diego-based Viking were up more than …

statnews.com

6%
OFF

Viking Therapeutics Faces Higher Bar For Oral Weight-loss Drug

6 days from now

Mar 11, 2024 · Viking Therapeutics Inc.’s stock fell 5.6% Friday, in a pullback from recent highs, after strong data from Novo Nordisk on an oral version of its weight-loss drug raised the …

marketwatch.com

$300
OFF

Viking To Charge Quickly Into Phase 3 With Obesity Med

6 days from now

Jul 25, 2024 · Viking Therapeutics will launch a longship into phase 3 for the obesity drug VK2735 sooner than expected, with a clinical program expected to top $300 million. ... Viking sails next …

fiercebiotech.com

60%
OFF

Viking Joins Obesity Drug Race After Promising Early Trial Data

6 days from now

Mar 28, 2023 · Viking Therapeutics Inc's experimental obesity drug helped reduce weight and was safe in an early-stage study, the company said on Tuesday, sparking a 60% rise in its shares.

reuters.com

15%
OFF

Viking Therapeutics Notches Success With Weight-loss Drug Trial, …

6 days from now

Feb 27, 2024 · Viking Therapeutics said on Tuesday its experimental drug helped patients with obesity lose nearly 15% of their body weight on average in a mid-stage study, and its share …

reuters.com

2%
OFF

Viking Therapeutics Is More Than Just A Weight-loss Stock, And

6 days from now

The company said obese adults taking the highest dose in a Phase 1 trial of 100 milligrams had an average weight loss of 8.2% from baseline over a four-week period. The 100 mg dose also …

msn.com

FAQs about Viking Therapeutics faces higher bar for oral weight-loss drug after ... Coupon?

Why did Viking Therapeutics stock rise 104% on Tuesday?

Viking Therapeutics stock soared as much as 104% on Tuesday after a successful drug trial. Viking's GLP-1 weight loss drug led to a significant reduction in body weight among patients. The drug could ultimately compete with weight loss drugs from Eli Lilly and Novo Nordisk if its Phase 3 trials prove successful. ...

Did Viking Therapeutics' weight-loss drug reduce body weight?

Patients saw ‘significant’ reductions in body weight during a study of a weight-loss drug developed by Viking Therapeutics. The U.S. Department of Justice has launched an antitrust investigation into UnitedHealth Group , the Wall Street Journal reported on Tuesday, citing people with knowledge of the matter. ...

Does Viking have an obesity pill?

Viking’s last update on its obesity pill was in early November at Obesity Week, an event organized by the Obesity Society. The company said obese adults taking the highest dose in a Phase 1 trial of 100 milligrams had an average weight loss of 8.2% from baseline over a four-week period. ...

Is Viking Therapeutics a takeover target?

Read now: Viking Therapeutics’ promising weight-loss drug data makes the company a takeover target The analysts noted that Viking is also developing a treatment for NASH, or nonalcoholic steatohepatitis, that produced promising liver-fat reduction in a Phase 1/2 trial. ...

What's going on with Viking Therapeutics?

She has a postgraduate degree in International Journalism from City, University of London. Viking Therapeutics shares reversed course to fall 8% on Monday as focus shifted to the drug developer's ability to mass produce its oral obesity treatment that was shown to be safe and effective in a small trial. ...

Does Viking Therapeutics' weight loss drug work faster than Ozempic or wegovy?

Viking Therapeutics' weight loss drug showed faster results in clinical trials than Ozempic or Wegovy. Here's how it works. A new injectable medication, similar to Ozempic and Mounjaro, is showing promising results for weight loss, and may help patients shed pounds even faster than the drugs currently on the market. ...